214 related articles for article (PubMed ID: 23923027)
21. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin expression and prognosis of oral cancer: a meta-analysis.
Luo SL; Xie YG; Li Z; Ma JH; Xu X
Tumour Biol; 2014 Jun; 35(6):5533-7. PubMed ID: 24573611
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
24. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer.
Zhang Y; Qian C; Jing L; Ren J; Guan Y
Oncotarget; 2017 Jul; 8(29):48272-48281. PubMed ID: 28537909
[TBL] [Abstract][Full Text] [Related]
26. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.
Fujikawa H; Tanaka K; Toiyama Y; Saigusa S; Inoue Y; Uchida K; Kusunoki M
J Gastroenterol; 2012 Jul; 47(7):775-84. PubMed ID: 22361863
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
28. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
29. Lack of effects of HER-2/neu on prognosis in colorectal cancer: a meta-analysis.
Han J; Meng QY; Liu X; Xi QL; Zhuang QL; Wu GH
Asian Pac J Cancer Prev; 2014; 15(14):5551-6. PubMed ID: 25081663
[TBL] [Abstract][Full Text] [Related]
30. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
[TBL] [Abstract][Full Text] [Related]
31. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
[TBL] [Abstract][Full Text] [Related]
32. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
33. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
35. Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma.
Foda AA; Mohammad MA; Abdel-Aziz A; El-Hawary AK
Tumour Biol; 2015 Jun; 36(6):4671-9. PubMed ID: 25619476
[TBL] [Abstract][Full Text] [Related]
36. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
37. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
39. Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
Wu Y; Chen C; Hua X; Zhao C; Min H
BMC Cancer; 2024 Apr; 24(1):537. PubMed ID: 38678238
[TBL] [Abstract][Full Text] [Related]
40. Claudin-7 downregulation induces metastasis and invasion in colorectal cancer via the promotion of epithelial-mesenchymal transition.
Wang K; Li T; Xu C; Ding Y; Li W; Ding L
Biochem Biophys Res Commun; 2019 Jan; 508(3):797-804. PubMed ID: 30528239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
